Clinical trial
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma: a Phase II Multicenter Study of the Fondazione Italiana Linfomi (FIL)
NCT01990144 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma: a Phase II Multicenter Study of the Fondazione Italiana Linfomi (FIL)
- Lead sponsor
- Fondazione Italiana Linfomi - ETS
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- February 29, 2016
- Enrollment
- 49 (estimated)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse large b-cell lymphoma